Mannkind (MNKD) Other Accumulated Expenses (2011 - 2026)
Mannkind's (MNKD) quarterly Other Accumulated Expenses came in at $2.8 million in Q1 2026, down 23.58% year-on-year from $3.6 million in Q1 2025, and down 7.09% on a QoQ basis from $3.0 million in Q4 2025.
Mannkind (MNKD) Other Accumulated Expenses (2011 - 2026) Analysis & Trends
Mannkind (MNKD) has 16 years of Other Accumulated Expenses data on file, last reported at $2.8 million in Q1 2026.
- On a quarterly basis, Other Accumulated Expenses fell 23.58% year-over-year to $2.8 million in Q1 2026; TTM through Mar 2026 was $2.8 million, a 23.58% decrease from a year earlier, with the FY2025 full-year figure at $3.0 million, down 31.34% from the prior year.
- Other Accumulated Expenses for Q1 2026 stood at $2.8 million, down from $3.0 million in the prior quarter.
- Over the last five years, Other Accumulated Expenses for MNKD reached as high as $5.6 million in Q2 2024 and fell as low as $2.5 million in Q1 2022.
- Historically, Other Accumulated Expenses has averaged $4.0 million across 5 years, with a median of $4.1 million in 2025.
- Across the five-year window, Other Accumulated Expenses soared 138.33% in 2022 and plunged 33.51% in 2025, its largest moves.
- Year by year, Other Accumulated Expenses stood at $4.7 million in 2022, then increased by 16.97% to $5.5 million in 2023, then declined by 21.11% to $4.4 million in 2024, then plunged by 31.34% to $3.0 million in 2025, then dropped by 7.09% to $2.8 million in 2026.
- Per Business Quant data, the three most recent Other Accumulated Expenses figures were $2.8 million in Q1 2026, $3.0 million in Q4 2025, and $4.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.78 Mn |
| Dec 31, 2025 | 2.99 Mn |
| Sep 30, 2025 | 4.06 Mn |
| Jun 30, 2025 | 4.52 Mn |
| Mar 31, 2025 | 3.64 Mn |
| Dec 31, 2024 | 4.36 Mn |
| Sep 30, 2024 | 4.14 Mn |
| Jun 30, 2024 | 5.59 Mn |
| Mar 31, 2024 | 5.47 Mn |
| Dec 31, 2023 | 5.52 Mn |
| Sep 30, 2023 | 3.40 Mn |
| Jun 30, 2023 | 4.11 Mn |
| Mar 31, 2023 | 3.45 Mn |
| Dec 31, 2022 | 4.72 Mn |
| Sep 30, 2022 | 2.98 Mn |
| Jun 30, 2022 | 3.33 Mn |
| Mar 31, 2022 | 2.47 Mn |
| Dec 31, 2021 | 1.98 Mn |
| Sep 30, 2021 | 1.31 Mn |
| Jun 30, 2021 | 1.56 Mn |